{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:48:51Z","timestamp":1760298531364},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"vor","delay-in-days":3336,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian Journal of Medical Microbiology"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.4103\/0255-0857.96703","type":"journal-article","created":{"date-parts":[[2012,5,28]],"date-time":"2012-05-28T05:25:59Z","timestamp":1338182759000},"page":"227-229","source":"Crossref","is-referenced-by-count":8,"title":["Relapse of kala-azar after use of multiple drugs: A case report and brief review of literature"],"prefix":"10.1016","volume":"30","author":[{"given":"K","family":"Pandey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SB","family":"Pun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BD","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4103\/0255-0857.96703_bib1","unstructured":"World Health Organization. Leishmaniasis Disease Burden. Available from: http:\/\/www.who.int\/leishmaniasis [Last accessed on 2011 Aug 24]."},{"key":"10.4103\/0255-0857.96703_bib2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-3156.2007.01974.x","article-title":"Implementation research to support the initiative on the elimination of kala-azar from Bangladesh, India and Nepal\u2013the challenges for diagnosis and treatment","volume":"13","author":"Sundar","year":"2008","journal-title":"Trop Med Int Health"},{"key":"10.4103\/0255-0857.96703_bib3","series-title":"Report of the Internal Assessment of Malaria Control and Kala-azar Elimination Activities","year":"2010"},{"key":"10.4103\/0255-0857.96703_bib4","unstructured":"WHO\/TDR. Press release: Elimination of kala-azar from endemic countries in the south-east Asia region. Health ministers\u2019 sign memorandum of understanding. Geneva\/New Delhi, May 18, 2005. Available from: http:\/\/www.who.int\/tdrold\/diseases\/leish\/press_release.htm. [Last accessed on 2008 June 10]."},{"key":"10.4103\/0255-0857.96703_bib5","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1086\/318121","article-title":"Failure of pentavalent antimony in visceral leishmaniasis in India: Report from the center of the Indian epidemic","volume":"31","author":"Sundar","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.4103\/0255-0857.96703_bib6","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0035-9203(03)90167-2","article-title":"Treatment of visceral leishmaniasis in south-eastern Nepal: Decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline","volume":"97","author":"Rijal","year":"2003","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.4103\/0255-0857.96703_bib7","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1473-3099(02)00347-X","article-title":"Visceral leishmaniasis: Current status of control, diagnosis, and treatment, and a proposed research and development agenda","volume":"2","author":"Guerin","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.4103\/0255-0857.96703_bib8","doi-asserted-by":"crossref","first-page":"580","DOI":"10.4269\/ajtmh.2009.80.580","article-title":"Relapse of visceral leishmaniasis after miltefosine treatment in a Nepalese patient","volume":"80","author":"Pandey","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.4103\/0255-0857.96703_bib9","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/380971","article-title":"Amphotericin B treatment for Indian visceral leishmaniasis: Conventional versus lipid formulations","volume":"38","author":"Sundar","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.4103\/0255-0857.96703_bib10","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1086\/318121","article-title":"Failure of pentavalent antimony in visceral leishmaniasis in India: Report from the center of the Indian epidemic","volume":"31","author":"Sundar","year":"2000","journal-title":"Clin Infect Dis"}],"container-title":["Indian Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085721009828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085721009828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T13:32:35Z","timestamp":1621517555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0255085721009828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0255085721009828"],"URL":"https:\/\/doi.org\/10.4103\/0255-0857.96703","relation":{},"ISSN":["0255-0857"],"issn-type":[{"value":"0255-0857","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}